Pharma Deals Review, Vol 2004, No 45 (2004)

Font Size:  Small  Medium  Large

Abbott Boosts Diabetes Unit through Acquisition of TheraSense

Business Review Editor

Abstract


Abbott Laboratories acquires diabetes products maker TheraSense for US$1.2 B. TheraSense’s products are FreeStyle®, a blood glucose self-monitoring system and continuous glucose-monitoring product, FreeStyle Navigator™.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.